CA2004364C - Oligonucleotides "antisense" de c-myb oncogene et leur utilisation - Google Patents
Oligonucleotides "antisense" de c-myb oncogene et leur utilisationInfo
- Publication number
- CA2004364C CA2004364C CA 2004364 CA2004364A CA2004364C CA 2004364 C CA2004364 C CA 2004364C CA 2004364 CA2004364 CA 2004364 CA 2004364 A CA2004364 A CA 2004364A CA 2004364 C CA2004364 C CA 2004364C
- Authority
- CA
- Canada
- Prior art keywords
- myb
- cells
- tct tcg
- ggg tct
- use according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US40802689A | 1989-09-15 | 1989-09-15 | |
US408,026 | 1989-09-15 | ||
US427,659 | 1989-10-27 | ||
US07/427,659 US5098890A (en) | 1988-11-07 | 1989-10-27 | Antisence oligonucleotides to c-myb proto-oncogene and uses thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2004364A1 CA2004364A1 (fr) | 1991-03-15 |
CA2004364C true CA2004364C (fr) | 1999-08-31 |
Family
ID=27020110
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA 2004364 Expired - Lifetime CA2004364C (fr) | 1989-09-09 | 1989-12-01 | Oligonucleotides "antisense" de c-myb oncogene et leur utilisation |
Country Status (1)
Country | Link |
---|---|
CA (1) | CA2004364C (fr) |
-
1989
- 1989-12-01 CA CA 2004364 patent/CA2004364C/fr not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
CA2004364A1 (fr) | 1991-03-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5098890A (en) | Antisence oligonucleotides to c-myb proto-oncogene and uses thereof | |
US5087617A (en) | Methods and compositions for treatment of cancer using oligonucleotides | |
US5248671A (en) | Methods and compositions for treatment of cancer using oligonucleotides | |
US5652222A (en) | Selective inhibition of leukemic cell proliferation by bcr-abl antisense oligonucleotides | |
WO1998014615A1 (fr) | Modulation oligonucleotidique antisens de l'expression genique a glyproteine-p resistant a plusieurs drogues (mdr) | |
AU2011301712B2 (en) | Method for reducing the number of certain circulating leukocytes in a human subject | |
EP0668782B1 (fr) | Combinaison d'un agent anti-neoplasique et d'oligonucleotides antisens dans le traitement du cancer | |
WO1994023755A1 (fr) | Nouveaux procedes et compositions destines au traitement du cancer active par ras au moyen d'oligonucleotides heterotypiques anti-raf et antisens | |
KR100695677B1 (ko) | 안티센스 조성물 및 암-치료 방법 | |
CA2004364C (fr) | Oligonucleotides "antisense" de c-myb oncogene et leur utilisation | |
CA1340369C (fr) | Oligonucleotides antisens pour le proto-oncogene c-myb et utilisations correspondantes | |
EP0667778A1 (fr) | Traitement d'un melanome au moyen d'oligonucleotides anti-codants par rapport au proto-oncogene c-myb | |
US5989849A (en) | Antisense of oligonucleotides to c-kit proto-oncogene and in vitro methods | |
AU785056B2 (en) | C-myc antisense-treated hematopoietic stem cell composition and method | |
JPH05500217A (ja) | c―ablプロト―オンコ遺伝子に対するアンチセンスオリゴヌクレオチド | |
WO1992019252A1 (fr) | Oligonucleotides non codants du proto-ontogene c-kit et leurs utilisations |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
MKLA | Lapsed | ||
MKEC | Expiry (correction) |
Effective date: 20121202 |